Related Experiment Video
Updated: Aug 5, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
Published on: April 27, 2016
Effects of Nutritional Supplements on Vascular Function: A Narrative Review
Eleni Katsanaki1, Georgios Georgiopoulos1, John Thymis1
12nd Department of Cardiology, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
Nutritional supplements may improve vascular function markers like blood pressure, but evidence for reducing major cardiovascular events is limited. More research is needed to confirm their role in cardiovascular prevention.
Area of Science:
- Cardiovascular Science
- Nutritional Science
- Aging Research
Background:
- Vascular aging contributes to cardiovascular risk through endothelial dysfunction, oxidative stress, and arterial stiffness.
- Nutritional supplements are being investigated for their potential to modulate these aging mechanisms.
- Endothelial glycocalyx alterations are a key feature of vascular aging.
Purpose of the Study:
- To review and critically evaluate evidence on nutritional supplements affecting endothelial function and vascular health.
- To examine proposed mechanisms of action and available preclinical/clinical data.
- To identify limitations in current research on supplements for vascular health.
Main Methods:
- Narrative review of scientific literature.
- Analysis of supplements targeting nitric oxide biology, polyphenols, mitochondrial function, and endothelial glycocalyx.
- Evaluation of studies on L-arginine/L-citrulline, cocoa flavan-3-ols, grape polyphenols, CoQ10, MitoQ, and others.
Main Results:
- Improvements noted in surrogate vascular endpoints like flow-mediated dilation, pulse wave velocity, and blood pressure.
- Significant heterogeneity and variable effect sizes observed across studies.
- Limited evidence exists for supplements reducing major cardiovascular events or mortality.
Conclusions:
- Several nutritional supplements show potential in improving surrogate markers of vascular function.
- Robust evidence for reducing clinical cardiovascular outcomes is currently lacking.
- Future research requires large, long-term RCTs with standardized formulations and clinically relevant outcomes.
Related Concept Videos
Overview of the Vascular System
Atherosclerosis III: Management
Antihypertensive Drugs: Vasodilators
Hypertension II: Pathophysiology
Regulation of Angiogenesis and Blood Supply
Hypertension and Regulation of Blood Pressure

